OPKO HEALTH INC (OPK)
US68375N1037 - Common Stock
Overall OPK gets a fundamental rating of 2 out of 10. We evaluated OPK against 116 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of OPK have multiple concerns. OPK has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year OPK has reported negative net income.
OPK had a negative operating cash flow in the past year.
OPK had negative earnings in 4 of the past 5 years.
In multiple years OPK reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of OPK (-9.39%) is worse than 65.52% of its industry peers.
OPK has a Return On Equity (-13.60%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.39% | ||
| ROE | -13.6% | ||
| ROIC | N/A |
ROA(3y)-8.6%
ROA(5y)-7.64%
ROE(3y)-12.14%
ROE(5y)-10.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 36.85%, OPK is in the better half of the industry, outperforming 63.79% of the companies in the same industry.
OPK's Gross Margin has been stable in the last couple of years.
OPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.85% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OPK has about the same amount of shares outstanding.
Compared to 5 years ago, OPK has more shares outstanding
Compared to 1 year ago, OPK has an improved debt to assets ratio.
2.2 Solvency
A Debt/Equity ratio of 0.15 indicates that OPK is not too dependend on debt financing.
OPK has a Debt to Equity ratio of 0.15. This is in the better half of the industry: OPK outperforms 74.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC7.84%
2.3 Liquidity
OPK has a Current Ratio of 1.55. This is a normal value and indicates that OPK is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.55, OPK is doing good in the industry, outperforming 62.93% of the companies in the same industry.
OPK has a Quick Ratio of 1.55. This is a normal value and indicates that OPK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, OPK is in the better half of the industry, outperforming 68.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.55 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 44.07% over the past year.
Looking at the last year, OPK shows a very negative growth in Revenue. The Revenue has decreased by -14.00% in the last year.
OPK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)44.08%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q18.18%
Revenue 1Y (TTM)-14%
Revenue growth 3Y-15.58%
Revenue growth 5Y-2.7%
Revenue growth Q2Q-1.83%
3.2 Future
OPK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.53% yearly.
OPK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.48% yearly.
EPS Next Y-51.87%
EPS Next 2Y-3.64%
EPS Next 3Y21.53%
EPS Next 5YN/A
Revenue Next Year-11.5%
Revenue Next 2Y-1.23%
Revenue Next 3Y2.48%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OPK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OPK's earnings are expected to grow with 21.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.64%
EPS Next 3Y21.53%
5. Dividend
5.1 Amount
OPK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OPKO HEALTH INC
NASDAQ:OPK (4/19/2024, 7:08:18 PM)
After market: 1.21 -0.02 (-1.63%)1.23
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap857.30M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.39% | ||
| ROE | -13.6% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.85% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)44.08%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-51.87%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14%
Revenue growth 3Y-15.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y